When is it safe for a woman with breast cancer to skip chemotherapy?
A new study helps answer that question, health based on a test of gene activity in tumors. It found that nearly half of women with early-stage breast cancer who would traditionally receive chemo can avoid it, health with little risk of the cancer coming back or spreading in the next five years.
The so-called genomic test measures the activity of genes that control the growth and spread of cancer, sale and can identify women with a low risk of recurrence and therefore little to gain from chemo.
“More and more evidence is mounting that there is a substantial number of women with breast cancer who will not need chemotherapy to do well,” said Dr. Rachel A. Freedman, a breast cancer oncologist at the Dana-Farber Cancer Institute in Boston. She was not involved in the study.
Read Full Article Here >>